ES2149234T3 - Bencenosulfonil-ureas y -tioureas sustituidas como antiarritmicos. - Google Patents

Bencenosulfonil-ureas y -tioureas sustituidas como antiarritmicos.

Info

Publication number
ES2149234T3
ES2149234T3 ES94120773T ES94120773T ES2149234T3 ES 2149234 T3 ES2149234 T3 ES 2149234T3 ES 94120773 T ES94120773 T ES 94120773T ES 94120773 T ES94120773 T ES 94120773T ES 2149234 T3 ES2149234 T3 ES 2149234T3
Authority
ES
Spain
Prior art keywords
equal
cycle
alq
fluor
hal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94120773T
Other languages
English (en)
Inventor
Heinrich Dr Englert
Dieter Dr Mania
Jens Dr Hartung
Heinz Dr Gogelein
Joachim Dr Kaiser
Uwe Dr Gerlach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2149234T3 publication Critical patent/ES2149234T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBEN UREA Y TIOUREA BENZOSULFONIL DE LA FORMULA I CON R(1) IGUAL A H, (CICLO)(CH2)A(FLUOR)ALQ(EN)IL, R(2) IGUAL A H, HAL, (FLUOR)(MERCAPTO)(CH2)E(CICLO)ALQ(OXI)(IL), NR(4)R(5) CON R(4) Y R(5) FORMANDO CONJUNTAMENTE UNA CADENA (CH2)2 - 7, O R(4), R(5), R(6) IGUAL A H, (ALQUIL)(CICLO) - (FLUOR)ALQ(EN)IL, E IGUAL A O, S; Y IGUAL A [CR(7)2]N - R(3) IGUAL A B IGUAL A (C3 -C6) - ALQUENIL O R(3) IGUAL A X IGUAL A H, HAL, ALQUIL; Z IGUAL HAL, (CICLO) - ALQU(IL)OXI. LOS COMPUESTO I SIRVEN PARA EL TRATAMIENTO DE PERTURBACIONES DEL RITMO CARDIACO Y PARA LA PREVENCION DE MUERTE CARDIACA REPENTINA, DE CONDICIONES ARRITMICAS Y PUEDEN POR ELLO ENCONTRAR UTILIZACION COMO MEDICAMENTOS ANTIARRITMICOS. SON APROPIADOS ESPECIALMENTE PARA TALES CASOS, EN DONDE LAS ARRITMIAS SON UNA CONSECUENCIA DEL ESTRECHAMIENTO DE LOS VASOS CORONARIOS, COMO EN EL CASO DE ANGINA DE PECHO O EL INFARTO DE MIOCARDIO AGUDO.
ES94120773T 1993-12-30 1994-12-27 Bencenosulfonil-ureas y -tioureas sustituidas como antiarritmicos. Expired - Lifetime ES2149234T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4344957A DE4344957A1 (de) 1993-12-30 1993-12-30 Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Herstellungsverfahren und Verwendungsmöglichkeiten pharmazeutischer Präparate auf Basis dieser Verbindungen

Publications (1)

Publication Number Publication Date
ES2149234T3 true ES2149234T3 (es) 2000-11-01

Family

ID=6506518

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94120773T Expired - Lifetime ES2149234T3 (es) 1993-12-30 1994-12-27 Bencenosulfonil-ureas y -tioureas sustituidas como antiarritmicos.

Country Status (19)

Country Link
EP (1) EP0661264B1 (es)
JP (1) JP3718248B2 (es)
KR (1) KR100370307B1 (es)
CN (1) CN1052976C (es)
AT (1) ATE194594T1 (es)
AU (1) AU679136B2 (es)
CA (1) CA2138930C (es)
DE (2) DE4344957A1 (es)
DK (1) DK0661264T3 (es)
ES (1) ES2149234T3 (es)
FI (1) FI107917B (es)
GR (1) GR3034513T3 (es)
HU (1) HU217122B (es)
IL (1) IL112172A (es)
NO (1) NO302750B1 (es)
NZ (1) NZ270265A (es)
PT (1) PT661264E (es)
TW (1) TW436481B (es)
ZA (1) ZA9410380B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19503136A1 (de) * 1995-02-01 1996-08-08 Hoechst Ag Substituierte Thiophenylsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU723895B2 (en) * 1997-01-29 2000-09-07 Pfizer Inc. Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
CN104203233A (zh) * 2011-10-26 2014-12-10 艾米丽·A·斯坦 用于影响神经功能的药剂、方法和设备
CN103420891B (zh) * 2013-06-09 2015-10-21 南通市华峰化工有限责任公司 Ⅱ型糖尿病药物格列美脲中间体苯磺胺三光气的合成方法
CN103601661B (zh) * 2013-09-22 2015-10-21 江苏德峰药业有限公司 Ⅱ型糖尿病药物格列美脲三光气的合成方法
CN103508932B (zh) * 2013-09-22 2015-06-10 江苏德峰药业有限公司 糖尿病药物格列美脲的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518874C3 (de) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE2951135A1 (de) * 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Also Published As

Publication number Publication date
NO945083D0 (no) 1994-12-29
ZA9410380B (en) 1995-08-29
HUT70830A (en) 1995-11-28
HU217122B (hu) 1999-11-29
GR3034513T3 (en) 2000-12-29
NZ270265A (en) 1995-10-26
NO945083L (no) 1995-07-03
AU8178994A (en) 1995-07-06
KR950017939A (ko) 1995-07-22
FI946136A0 (fi) 1994-12-28
PT661264E (pt) 2000-12-29
CA2138930A1 (en) 1995-07-01
DE59409440D1 (de) 2000-08-17
FI946136A7 (fi) 1995-07-01
FI107917B (fi) 2001-10-31
AU679136B2 (en) 1997-06-19
CN1109872A (zh) 1995-10-11
KR100370307B1 (ko) 2003-10-11
CA2138930C (en) 2006-01-17
DE4344957A1 (de) 1995-07-06
HU9403803D0 (en) 1995-02-28
DK0661264T3 (da) 2000-10-23
NO302750B1 (no) 1998-04-20
JP3718248B2 (ja) 2005-11-24
EP0661264A1 (de) 1995-07-05
JPH07206807A (ja) 1995-08-08
TW436481B (en) 2001-05-28
EP0661264B1 (de) 2000-07-12
CN1052976C (zh) 2000-05-31
ATE194594T1 (de) 2000-07-15
IL112172A0 (en) 1995-03-15
IL112172A (en) 1999-03-12

Similar Documents

Publication Publication Date Title
ES2098069T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos.
GR3022571T3 (en) Use of sulfonamides as drug and new sulfonamides
NO180045C (no) Cykliske iminoderivater, og legemiddelpreparater inneholdende dem
DE69127690D1 (de) Antiatherosklerotische und antithrombotische 1-benzopyran-4-on- und 2-amino-1,3-benzoxazin-4-on-derivate
ES2061587T3 (es) Compuestos aromaticos y heteroaromaticos alfa,alfa-disustituidos como mejoradores de la cognicion.
ES2149234T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas como antiarritmicos.
ATE5525T1 (de) Tragbehaelter.
ES2096840T3 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su uso como medicamento o agente para diagnostico, asi como medicamento que las contiene.
DE69300396D1 (de) Isothermischer Behälter, insbesondere für den Transport von frischen oder tiefgefrorenen Waren.
ES2059301T3 (es) Utilizacion de inhibidores de la enzima convertidora de angiotensina para el tratamiento de la aterosclerosis, trombosis y de la enfermedad vascular periferica.
ES2127875T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas con amino, procedimiento para su preparacion y su utilizacion como productos farmaceuticos.
DK464885D0 (da) Tetrahydronaphthalenderivater
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
PT89207A (pt) Processo para a preparcao de derivados de ciclopropano e de produtos intermediarios
NO871282D0 (no) Forbindelser med nootrop virkning, midler som inneholder disse og deres anvendelse ved behandling og profylakse og kognitive dysfunksjoner.
ES8306476A1 (es) Derivados de guanidina.
ES2142895T3 (es) Guanidinas sustituidas con diacilo, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
PT90814A (pt) Processo de preparacao de derivados da fenotiazina
DE3786461D1 (de) Mehrfachpackung.
TR199800577A2 (xx) Orto-�kameli benzoilguanidin'ler, bunlar�n �retim us�l�.
RU94038305A (ru) Способ получения 2,4-ди(алкиламино)-6-алкилтио-s-триазинов
TH18923A (es)
IE802351L (en) Antiarrhythmic tetrahydronaphthalene derivatives
IT1254471B (it) Derivati ammidici della (r)-glicerofosforil-(s)-serina o del suo diacil derivato, un processo per la loro preparazione e relative composizioni farmaceutiche per il potenziamento dei processi di apprendimento
TH2017A (th) เบนโซอิลยูเรีย

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661264

Country of ref document: ES